BlackRock Fund Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

BlackRock Fund Advisors’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12K	Buy	5,563 +1,080	+24%	+$2.25K	﹤0.01%	3942
2016 Q3	$8K	Buy	4,483 +459	+11%	+$558	﹤0.01%	4002
2016 Q2	$3K	Sell	4,024 -43,094	-91%	-$33.4K	﹤0.01%	4191
2016 Q1	$42K	Sell	47,118 -3,490	-7%	-$3.51K	﹤0.01%	3841
2015 Q4	$56K	Buy	50,608 +2,295	+5%	+$4.92K	﹤0.01%	3849
2015 Q3	$102K	Buy	48,313 +8,529	+21%	+$16.6K	﹤0.01%	3697
2015 Q2	$79K	Sell	39,784 -340,396	-90%	-$965K	﹤0.01%	3771
2015 Q1	$1.47M	Sell	380,180 -2,758	-0.7%	-$10.2K	﹤0.01%	3181
2014 Q4	$1.38M	Buy	382,938 +65,021	+20%	+$172K	﹤0.01%	3203
2014 Q3	$846K	Buy	317,917 +47,675	+18%	+$319K	﹤0.01%	3201
2014 Q2	$3.14M	Buy	270,242 +115,413	+75%	+$1.31M	﹤0.01%	3053
2014 Q1	$2.16M	Buy	154,829 +8,186	+6%	+$129K	﹤0.01%	3129
2013 Q4	$2.61M	Sell	146,643 -6,117	-4%	-$99.4K	﹤0.01%	3099
2013 Q3	$2.57M	Buy	+152,760	New	+$2.14M	﹤0.01%	3083

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWS

AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return

BlackRock Fund Advisors's MBII Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Marrone Bio Innovations, Inc. (MBII) stake by 24% in Q4 2016, buying an estimated $2.25K and bringing the position to 5,563 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3942.

BlackRock Fund Advisors first reported a position in MBII in Q3 2013 and has held it in 14 quarters since. The position peaked at $3.14M in Q2 2014. 23 funds tracked by Wall St. Rank hold MBII as of Q4 2016.

BlackRock Fund Advisors held 5,563 shares of Marrone Bio Innovations, Inc. worth $12K as of Q4 2016.
BlackRock Fund Advisors bought 1,080 Marrone Bio Innovations, Inc. shares in Q4 2016, an estimated $2.25K.
Marrone Bio Innovations, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3942 holding.
BlackRock Fund Advisors first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and has held it in 14 quarters since.
BlackRock Fund Advisors's Marrone Bio Innovations, Inc. position peaked at $3.14M in Q2 2014.
23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.